Delhi HC also petitioned on drug ban

The government had ordered banning of 344 fixed dose combinations

Half of online drug orders end up getting cancelled
Gireesh Babu Chennai
Last Updated : Mar 23 2016 | 5:54 PM IST

The Indian Drug Manufacturers Association, a body of domestic drug makers, has moved the Delhi High Court against the government order banning 344 fixed dose combinations (FDCs). Filed last week with the Federation of Pharma Enterpreneurs, it is to be heard on Monday, say sources.

The associations argue these drugs, banned on the reasoning of irrationality, has been used by people across the country, based on prescription, for several decades and no major adverse reaction was reported.

The central government announced a ban on 344 FDCs on March 10, after a panel of experts said these lacked therapeutic effects and had health risks. Following this, at least 20 drug companies moved various high courts, seeking revocation of the decision.

On Tuesday, the high court here refused to give a stay on the government order, on a petition filed by the Federation of South Indian Pharmaceutical Manufacturers Association.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 23 2016 | 5:42 PM IST

Next Story